1 In a proof-of-concept approach,
we explored a clinically translatable intronic CRISPR (cluste
2 Therefore,
we explored a model where DNA accessibility is not the result
3 Here,
we explored autophagy as a mechanism to reduce tau burden in
4 We explored barriers to MOUD uptake using chart review.
5 We explored changes in gene expression profiles among patient
6 We explored confirmatory re-testing scenarios of repeating al
7 sed GVHD treatment regimens target the donor immune system,
we explored here an approach that aims at protecting and rege
8 We explored here the oligomerization of a structurally divers
9 We explored how altered endocytic uptake, water reabsorption,
10 We explored how bacterial community composition and underlyin
11 Using simulations and analytical results,
we explored how different types of habitat modifications (tha
12 In the course of this study
we explored plausible alternative pathways for H(2) activatio
13 Finally,
we explored possible explanations for the experimental discre
14 We explored possible origins of this high residual diversity,
15 Here,
we explored small RNAs diversity and expression in the contex
16 Therefore,
we explored the association between plasma folate, vitamin B-
17 We explored the behavioral observations that corroborate evid
18 In this study,
we explored the biochemical properties of a chloroplastic Clp
19 We explored the biology of co-expressed genes using bioinform
20 To address this,
we explored the cell-intrinsic mechanisms of constitutive PD-
21 We explored the clinical significance and predictive value of
22 In this study,
we explored the effect of calcitriol on homeostatic (M-CSF, T
23 tment modalities for patients who progress on chemotherapy,
we explored the effects of long-term gemcitabine administrati
24 Using this inhibitor,
we explored the enzymatic function of TET proteins during som
25 Here,
we explored the function of this kinase in macrophages with s
26 We explored the hypothesis that nicotine increases NGF by red
27 Finally,
we explored the individual cancer histologies in which these
28 Here,
we explored the mechanisms underlying MHV68 activation of SIN
29 Here
we explored the molecular mechanisms by which Trial 2 achieve
30 We explored the multiscale organization of human connectomes
31 Here,
we explored the neuroprotective effects of pharmacologically
32 Next,
we explored the possibility to culture cells and tissues in t
33 We explored the potential for autophagy to regulate budding y
34 adily undergoes liquid-liquid phase separation (LLPS), here
we explored the relationship between disease-related mutation
35 We explored the relationship between Notch signaling and gobl
36 We explored the relationship between time from diagnosis to t
37 In the present study,
we explored the role of interneurons in this circuit.
38 We explored the role of intrahepatic LCN2 in human alcoholic
39 Here,
we explored the role of this USP (USP(4207)) in M. smegmatis
40 Finally,
we explored the roles of the leader peptide and of the RiPP p
41 Here
we explored the utility of chimeric antigen receptor (CAR) T
42 We explored this issue using the yeast Pichia pastoris.
43 We explored three approaches to the design of splint oligonuc
44 We explored unsupervised machine learning of ECG waveforms to
45 and labeling single CA2/CA3 neurons in freely-moving mice,
we explored whether and how burst propensity relates to pyram
46 We explored whether currently available T2-targeting drugs ca
47 We explored whether ipRGC function in DR is associated with c
48 We explored whether meal rankings according to postprandial g
49 In a subset,
we explored whether the association between UMFA and ASD risk
50 We explored whether the epigenetic markers, circulating micro